Results 91 to 100 of about 2,245,112 (263)

Immunosuppressive Drug Use in Limited Systemic Sclerosis: An International Survey

Arthritis Care &Research, EarlyView.
Objective Current guidelines recommend immunosuppressive treatment for diffuse cutaneous systemic sclerosis but are less clear on their use in limited cutaneous systemic sclerosis (lcSSc) in the absence of internal organ complications. We conducted an international survey to understand current immunosuppressive drug prescribing patterns in lcSSc ...
Sabrina Hoa, Yicheng Mu, Marie Hudson, Janet Pope   +3 more
wiley   +1 more source

The readiness of pediatric rheumatology patients and their parents to transition to adult-oriented treatment

, 2021
Introduction Transition is a planned process of pediatric patients from child-centered to adult-oriented treatment. Transitional care for patients with chronic diseases is essential.
AKTAY AYAZ, Nuray, SÖNMEZ, HAFİZE EMİNE, Koc, Rahime, Hafize Emine Sönmez, Rahime Koç, Şerife Gül Karadağ, Nuray Aktay Ayaz, Karadag, Serife Gul   +7 more
core   +1 more source

The Gut–Heart Axis in Systemic Sclerosis: Evidence From a Large Prospective Early Disease Cohort

Arthritis Care &Research, EarlyView.
Objective Cardiac involvement significantly impacts prognosis in systemic sclerosis (SSc), highlighting the need for early risk stratification. Gastrointestinal (GI) symptoms are common and often manifest early. Emerging data suggest a link between GI and cardiac manifestations, possibly through shared mechanisms like dysautonomia.
Francesca R. Di Ciommo, Ashish P. Balar, Aidan K. Strother, Subhash Kulkarni, Michael Hughes, Brian Skaug, Maureen D. Mayes, Shervin Assassi, Ali Y. Ayla, Zsuzsanna H. McMahan   +9 more
wiley   +1 more source

Distinct Systemic Sclerosis Phenotypes Related to Ethnicity: An Opportunity to Personalize Care?

Arthritis Care &Research, EarlyView.
Objective The objective is to describe and compare demographic, clinical, and serological characteristics of patients with systemic sclerosis (SSc) according to ethnic background. Methods Participants enrolled in the Canadian Scleroderma Research Group cohort who self‐identified to a single ethnicity group were included.
Danick Goulet, Camille Guertin, Maggie Larché, Isabelle Ferdinand, Marie Hudson, May Y. Choi, Mohammed Osman, Janet Pope, Carter Thorne, Murray Baron, Sasha Bernatsky, Sabrina Hoa   +11 more
wiley   +1 more source

Rheumatic diseases and multimorbidity

Terapevticheskii arkhiv, 2015
In the past decade, investigators' undeniable and justified interest has not been fading in comorbidities in the presence of rheumatic diseases. The terms "comorbidity" and "multimorbidity" are frequently and not always consciously used as interinterchangeable, confusing the terminology and accordingly the elaboration of strategies for further ...
E L Nasonov, A V Gordeev, E A Galushko
openaire   +3 more sources

Real‐World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity‐Matched Study From the EUSTAR Cohort

Arthritis Care &Research, EarlyView.
Objective JAK inhibitors (JAKi) have shown promising effects in early‐phase studies of systemic sclerosis (SSc). We aimed to assess the safety and explore the effectiveness of JAKi compared to conventional immunosuppressants in SSc. Methods A longitudinal retrospective study of the European Scleroderma Trials and Research Group (EUSTAR) cohort was ...
Stefano Di Donato, Marie‐Elise Truchetet, Marco Minerba, Oliver Distler, Juan José Alegre Sancho, Yolanda Braun‐Moscovici, Christina Bergmann, Petros Sfikakis, Jeska K. de Vries‐Bouwstra, Murray Baron, Silvia Bellando‐Randone, Lorenzo Dagna, Christopher P. Denton, Madelon C. Vonk, Vanessa Smith, Ivan Castellvi, Gabriela Riemekasten, Andra Balanescu, Masataka Kuwana, Maria De Santis, Kamal Solanki, Anastas Batalov, Vahan Mukuchyan, Marco Matucci‐Cerinic, Yannick Allanore, Francesco Del Galdo, Michael Hughes, EUSTAR Collaborators   +27 more
wiley   +1 more source

Update on Rheumatic Diseases in Clinical Practice

: Diagnostic imaging is essential in the diagnostic process of rheumatic diseases. Given the heterogeneity of this group of diseases and the tremendous impact of novel therapeutic options, guidelines and recommendations regarding the optimal choice of ...
Rennie, Winston, Sudol-Szopinska, Iwona, Zanatta, Elisabetta, Bazzocchi, Alberto, Evangelista, Laura, Del Grande, Filippo, Giraudo, Chiara, Stramare, Roberto, Fichera, Giulia, Guglielmi, Giuseppe   +9 more
core   +1 more source

Validation of the educational needs assessment tool as a generic instrument for rheumatic diseases in seven European countries [PDF]

, 2013
Objectives To validate the educational needs assessment tool (ENAT) as a generic tool for assessing the educational needs of patients with rheumatic diseases in European Countries.
Tennant, Alan, Stamm, Tanja A., Machado, Pedro,, Zangi, Heidi A., Horton, Mike,, Vliet Vlieland, Theodora P.M., Bremander, A., De La Torre-Aboki, Jenny, Zangi, Heidi A.,, Kukkurainen, M.L., Tennant, A., Stamm, Tanja A.,, Bremander, Ann, Vliet Vlieland, Theodora P M, de la Torre-Aboki, Jenny,, Hamnes, Bente,, Vliet Vlieland, Theodora P. M.,, Horton, Mike, Vlieland, T.P.M.V., Hill, Jackie,, Torre-Aboki, J. de la, Hamnes, B, Horton, M, Stamm, T.A., Ndosi, Mwidimi,, Hamnes, Bente, Tennant, Alan,, Hill, J, Horton, M., Zangi, Heidi A, Tennant, A, Ndosi, ME, Bremander, A, Machado, Pedro, Stamm, T, Kukkurainen, ML, Marques, Andrea, Machado, P, Hill, Jackie, Ndosi, M., Bremander, Ann,, Meesters, J., Marques, Andrea,, Meesters, Jorit, Kukkurainen, Marja Leena,, Vliet Vlieland, TPM, Machado, P., Marques, A., Ndosi, Mwidimi, Marques, A, Meesters, J, Meesters, Jorit,, Hamnes, B., Hill, J., Kukkurainen, Marja Leena, Stamm, Tanja A, Zangi, H.A., de la Torre-Aboki, J, Zangi, H   +58 more
core   +1 more source

Anorectal Dysfunction in Systemic Sclerosis: Clinical Phenotypes and Functional Patterns

Arthritis Care &Research, EarlyView.
Objective The aim of this study was to characterize specific physiologic defects in anorectal dysfunction in systemic sclerosis (SSc) using anorectal manometry (ARM), evaluate associations with gastrointestinal (GI) and extraintestinal clinical phenotypes, and explore potential serologic markers for risk stratification.
Timothy Kaniecki, Alireza Amindarolzarbi, Tsion Abdi, John Clarke, Michael Hughes, Ami A. Shah, Zsuzsanna H. McMahan   +6 more
wiley   +1 more source

DIFFERENTIATION IN RHEUMATIC DISEASES. [PDF]

The Lancet, 1890
n ...
openaire   +2 more sources